Global Xeljanz (tofacitnib) Drug Market Research Report 2023

Report ID: 1897681 | Published Date: Jan 2025 | No. of Page: 72 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Xeljanz (tofacitnib) Drug Market Overview
    1.1 Product Overview and Scope of Xeljanz (tofacitnib) Drug
    1.2 Xeljanz (tofacitnib) Drug Segment by Type
        1.2.1 Global Xeljanz (tofacitnib) Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Tablets
        1.2.3 Extended-release Tablets
    1.3 Xeljanz (tofacitnib) Drug Segment by Application
        1.3.1 Global Xeljanz (tofacitnib) Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Rheumatoid Arthritis
        1.3.3 Psoriatic Arthritis
        1.3.4 Other
    1.4 Global Xeljanz (tofacitnib) Drug Market Size Estimates and Forecasts
        1.4.1 Global Xeljanz (tofacitnib) Drug Revenue 2017-2028
        1.4.2 Global Xeljanz (tofacitnib) Drug Sales 2017-2028
        1.4.3 Xeljanz (tofacitnib) Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Xeljanz (tofacitnib) Drug Market Competition by Manufacturers
    2.1 Global Xeljanz (tofacitnib) Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Xeljanz (tofacitnib) Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Xeljanz (tofacitnib) Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Xeljanz (tofacitnib) Drug Manufacturing Sites, Area Served, Product Type
    2.5 Xeljanz (tofacitnib) Drug Market Competitive Situation and Trends
        2.5.1 Xeljanz (tofacitnib) Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Xeljanz (tofacitnib) Drug Players Market Share by Revenue
        2.5.3 Global Xeljanz (tofacitnib) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Xeljanz (tofacitnib) Drug Retrospective Market Scenario by Region
    3.1 Global Xeljanz (tofacitnib) Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Xeljanz (tofacitnib) Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Xeljanz (tofacitnib) Drug Market Facts & Figures by Country
        3.3.1 North America Xeljanz (tofacitnib) Drug Sales by Country
        3.3.2 North America Xeljanz (tofacitnib) Drug Revenue by Country
        3.3.3 the United States
        3.3.4 Canada
    3.4 Europe Xeljanz (tofacitnib) Drug Market Facts & Figures by Country
        3.4.1 Europe Xeljanz (tofacitnib) Drug Sales by Country
        3.4.2 Europe Xeljanz (tofacitnib) Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 UK
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Xeljanz (tofacitnib) Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Xeljanz (tofacitnib) Drug Sales by Region
        3.5.2 Asia Pacific Xeljanz (tofacitnib) Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Xeljanz (tofacitnib) Drug Market Facts & Figures by Country
        3.6.1 Latin America Xeljanz (tofacitnib) Drug Sales by Country
        3.6.2 Latin America Xeljanz (tofacitnib) Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Xeljanz (tofacitnib) Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Xeljanz (tofacitnib) Drug Sales by Country
        3.7.2 Middle East and Africa Xeljanz (tofacitnib) Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Xeljanz (tofacitnib) Drug Historic Market Analysis by Type
    4.1 Global Xeljanz (tofacitnib) Drug Sales Market Share by Type (2017-2022)
    4.2 Global Xeljanz (tofacitnib) Drug Revenue Market Share by Type (2017-2022)
    4.3 Global Xeljanz (tofacitnib) Drug Price by Type (2017-2022)
5 Global Xeljanz (tofacitnib) Drug Historic Market Analysis by Application
    5.1 Global Xeljanz (tofacitnib) Drug Sales Market Share by Application (2017-2022)
    5.2 Global Xeljanz (tofacitnib) Drug Revenue Market Share by Application (2017-2022)
    5.3 Global Xeljanz (tofacitnib) Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Pfizer
        6.1.1 Pfizer Corporation Information
        6.1.2 Pfizer Description and Business Overview
        6.1.3 Pfizer Xeljanz (tofacitnib) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Pfizer Xeljanz (tofacitnib) Drug Product Portfolio
        6.1.5 Pfizer Recent Developments/Updates
7 Xeljanz (tofacitnib) Drug Manufacturing Cost Analysis
    7.1 Xeljanz (tofacitnib) Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Xeljanz (tofacitnib) Drug
    7.4 Xeljanz (tofacitnib) Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Xeljanz (tofacitnib) Drug Distributors List
    8.3 Xeljanz (tofacitnib) Drug Customers
9 Xeljanz (tofacitnib) Drug Market Dynamics
    9.1 Xeljanz (tofacitnib) Drug Industry Trends
    9.2 Xeljanz (tofacitnib) Drug Market Drivers
    9.3 Xeljanz (tofacitnib) Drug Market Challenges
    9.4 Xeljanz (tofacitnib) Drug Market Restraints
10 Global Market Forecast
    10.1 Xeljanz (tofacitnib) Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Xeljanz (tofacitnib) Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Xeljanz (tofacitnib) Drug by Type (2023-2028)
    10.2 Xeljanz (tofacitnib) Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Xeljanz (tofacitnib) Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Xeljanz (tofacitnib) Drug by Application (2023-2028)
    10.3 Xeljanz (tofacitnib) Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Xeljanz (tofacitnib) Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Xeljanz (tofacitnib) Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Xeljanz (tofacitnib) Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Xeljanz (tofacitnib) Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Xeljanz (tofacitnib) Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Xeljanz (tofacitnib) Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Xeljanz (tofacitnib) Drug Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Xeljanz (tofacitnib) Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Xeljanz (tofacitnib) Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Xeljanz (tofacitnib) Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Xeljanz (tofacitnib) Drug Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Xeljanz (tofacitnib) Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers Xeljanz (tofacitnib) Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Xeljanz (tofacitnib) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xeljanz (tofacitnib) Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Xeljanz (tofacitnib) Drug Sales by Region (2017-2022) & (K Units)
    Table 16. Global Xeljanz (tofacitnib) Drug Sales Market Share by Region (2017-2022)
    Table 17. Global Xeljanz (tofacitnib) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Xeljanz (tofacitnib) Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America Xeljanz (tofacitnib) Drug Sales by Country (2017-2022) & (K Units)
    Table 20. North America Xeljanz (tofacitnib) Drug Sales Market Share by Country (2017-2022)
    Table 21. North America Xeljanz (tofacitnib) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Xeljanz (tofacitnib) Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe Xeljanz (tofacitnib) Drug Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Xeljanz (tofacitnib) Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe Xeljanz (tofacitnib) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Xeljanz (tofacitnib) Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Xeljanz (tofacitnib) Drug Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Xeljanz (tofacitnib) Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Xeljanz (tofacitnib) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Xeljanz (tofacitnib) Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Xeljanz (tofacitnib) Drug Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Xeljanz (tofacitnib) Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America Xeljanz (tofacitnib) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Xeljanz (tofacitnib) Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Xeljanz (tofacitnib) Drug Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Xeljanz (tofacitnib) Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Xeljanz (tofacitnib) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Xeljanz (tofacitnib) Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global Xeljanz (tofacitnib) Drug Sales by Type (2017-2022) & (K Units)
    Table 40. Global Xeljanz (tofacitnib) Drug Sales Market Share by Type (2017-2022)
    Table 41. Global Xeljanz (tofacitnib) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Xeljanz (tofacitnib) Drug Revenue Share by Type (2017-2022)
    Table 43. Global Xeljanz (tofacitnib) Drug Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Xeljanz (tofacitnib) Drug Sales (K Units) by Application (2017-2022)
    Table 45. Global Xeljanz (tofacitnib) Drug Sales Market Share by Application (2017-2022)
    Table 46. Global Xeljanz (tofacitnib) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Xeljanz (tofacitnib) Drug Revenue Share by Application (2017-2022)
    Table 48. Global Xeljanz (tofacitnib) Drug Price by Application (2017-2022) & (USD/Unit)
    Table 49. Pfizer Corporation Information
    Table 50. Pfizer Description and Business Overview
    Table 51. Pfizer Xeljanz (tofacitnib) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Pfizer Xeljanz (tofacitnib) Drug Product
    Table 53. Pfizer Recent Developments/Updates
    Table 54. Production Base and Market Concentration Rate of Raw Material
    Table 55. Key Suppliers of Raw Materials
    Table 56. Xeljanz (tofacitnib) Drug Distributors List
    Table 57. Xeljanz (tofacitnib) Drug Customers List
    Table 58. Xeljanz (tofacitnib) Drug Market Trends
    Table 59. Xeljanz (tofacitnib) Drug Market Drivers
    Table 60. Xeljanz (tofacitnib) Drug Market Challenges
    Table 61. Xeljanz (tofacitnib) Drug Market Restraints
    Table 62. Global Xeljanz (tofacitnib) Drug Sales Forecast by Type (2023-2028) & (K Units)
    Table 63. Global Xeljanz (tofacitnib) Drug Sales Market Share Forecast by Type (2023-2028)
    Table 64. Global Xeljanz (tofacitnib) Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 65. Global Xeljanz (tofacitnib) Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 66. Global Xeljanz (tofacitnib) Drug Sales Forecast by Application (2023-2028) & (K Units)
    Table 67. Global Xeljanz (tofacitnib) Drug Sales Market Share Forecast by Application (2023-2028)
    Table 68. Global Xeljanz (tofacitnib) Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 69. Global Xeljanz (tofacitnib) Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 70. Global Xeljanz (tofacitnib) Drug Sales Forecast by Region (2023-2028) & (K Units)
    Table 71. Global Xeljanz (tofacitnib) Drug Sales Market Share Forecast by Region (2023-2028)
    Table 72. Global Xeljanz (tofacitnib) Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 73. Global Xeljanz (tofacitnib) Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 74. Research Programs/Design for This Report
    Table 75. Key Data Information from Secondary Sources
    Table 76. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Xeljanz (tofacitnib) Drug
    Figure 2. Global Xeljanz (tofacitnib) Drug Market Share by Type in 2021 & 2028
    Figure 3. Tablets Product Picture
    Figure 4. Extended-release Tablets Product Picture
    Figure 5. Global Xeljanz (tofacitnib) Drug Market Share by Application in 2021 & 2028
    Figure 6. Rheumatoid Arthritis
    Figure 7. Psoriatic Arthritis
    Figure 8. Other
    Figure 9. Global Xeljanz (tofacitnib) Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Xeljanz (tofacitnib) Drug Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Xeljanz (tofacitnib) Drug Sales (2017-2028) & (K Units)
    Figure 12. Xeljanz (tofacitnib) Drug Sales Share by Manufacturers in 2021
    Figure 13. Global Xeljanz (tofacitnib) Drug Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Xeljanz (tofacitnib) Drug Players: Market Share by Revenue in 2021
    Figure 15. Xeljanz (tofacitnib) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Xeljanz (tofacitnib) Drug Sales Market Share by Region (2017-2022)
    Figure 17. Global Xeljanz (tofacitnib) Drug Sales Market Share by Region in 2021
    Figure 18. Global Xeljanz (tofacitnib) Drug Revenue Market Share by Region (2017-2022)
    Figure 19. Global Xeljanz (tofacitnib) Drug Revenue Market Share by Region in 2021
    Figure 20. the United States Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. UK Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Turkey Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Saudi Arabia Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. UAE Xeljanz (tofacitnib) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Sales Market Share of Xeljanz (tofacitnib) Drug by Type (2017-2022)
    Figure 43. Manufacturing Cost Structure of Xeljanz (tofacitnib) Drug
    Figure 44. Manufacturing Process Analysis of Xeljanz (tofacitnib) Drug
    Figure 45. Xeljanz (tofacitnib) Drug Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Frequently Asked Questions
Xeljanz (tofacitnib) Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Xeljanz (tofacitnib) Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Xeljanz (tofacitnib) Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Wound & Tissue Care

Wound & Tissue Care market is segmented by players, region (country), by Type and by Application. ... Read More

Electronic Massager

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More